Variant report
Variant | esv1842813 |
---|---|
Chromosome Location | chr12:84579418-84595585 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr12:84583913-84583956 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | EP300 | chr12:84579954-84580612 | SK-N-SH_RA | brain: | n/a | n/a |
3 | EP300 | chr12:84579885-84580873 | SK-N-SH | brain: | n/a | n/a |
4 | EP300 | chr12:84579835-84580754 | SK-N-SH | brain: | n/a | n/a |
5 | EP300 | chr12:84584808-84585103 | SK-N-SH_RA | brain: | n/a | n/a |
6 | EP300 | chr12:84579907-84580671 | SK-N-SH_RA | brain: | n/a | n/a |
7 | EP300 | chr12:84579965-84580860 | SK-N-SH | brain: | n/a | n/a |
8 | FOSL2 | chr12:84580016-84580730 | SK-N-SH | brain: | n/a | n/a |
9 | FOXM1 | chr12:84580208-84580679 | SK-N-SH | brain: | n/a | n/a |
10 | FOXM1 | chr12:84580127-84580698 | SK-N-SH | brain: | n/a | n/a |
11 | GATA2 | chr12:84580236-84580509 | SH-SY5Y | brain: | n/a | n/a |
12 | GATA3 | chr12:84579876-84580843 | SK-N-SH | brain: | n/a | n/a |
13 | GATA3 | chr12:84580387-84580493 | SH-SY5Y | brain: | n/a | n/a |
14 | GATA3 | chr12:84579976-84580774 | SK-N-SH | brain: | n/a | n/a |
15 | JUND | chr12:84580040-84580748 | SK-N-SH | brain: | n/a | n/a |
16 | JUND | chr12:84579967-84580721 | SK-N-SH | brain: | n/a | n/a |
17 | MYC | chr12:84587913-84587921 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | NFIC | chr12:84580107-84580598 | SK-N-SH | brain: | n/a | n/a |
19 | NFIC | chr12:84579908-84580870 | SK-N-SH | brain: | n/a | n/a |
20 | PBX3 | chr12:84580025-84580695 | SK-N-SH | brain: | n/a | n/a |
21 | PBX3 | chr12:84579842-84580765 | SK-N-SH | brain: | n/a | n/a |
22 | POLR2A | chr12:84580218-84580532 | SK-N-SH | brain: | n/a | n/a |
23 | POLR2A | chr12:84581064-84581264 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr12:84586439-84586444 | Gliobla | brain: | n/a | n/a |
25 | POLR2A | chr12:84595036-84595132 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | POLR2A | chr12:84580087-84580551 | SK-N-SH | brain: | n/a | n/a |
27 | POLR2A | chr12:84584778-84584877 | ProgFib | skin: | n/a | n/a |
28 | POLR2A | chr12:84588901-84589141 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | RAD21 | chr12:84580103-84580545 | SK-N-SH_RA | brain: | n/a | chr12:84580451-84580470 |
30 | RAD21 | chr12:84580096-84580515 | SK-N-SH_RA | brain: | n/a | chr12:84580451-84580470 |
31 | RXRA | chr12:84580160-84580683 | SK-N-SH | brain: | n/a | n/a |
32 | STAT3 | chr12:84579890-84580183 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | STAT3 | chr12:84581712-84581799 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr12:84592508-84592682 | MCF10A-Er-Src | breast: | n/a | chr12:84592568-84592579 |
35 | TAF1 | chr12:84580329-84580485 | SK-N-SH | brain: | n/a | n/a |
36 | TCF12 | chr12:84579974-84580792 | SK-N-SH | brain: | n/a | n/a |
37 | TCF12 | chr12:84579885-84580919 | SK-N-SH | brain: | n/a | n/a |
38 | TEAD4 | chr12:84580032-84580813 | SK-N-SH | brain: | n/a | chr12:84580353-84580362 |
39 | TEAD4 | chr12:84580068-84580778 | SK-N-SH | brain: | n/a | chr12:84580353-84580362 |
40 | ZBTB33 | chr12:84580160-84580668 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221148 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1482436 | chr12:84579418-84579419 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs556950923 | chr12:84579419-84579420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140974368 | chr12:84579435-84579436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545883006 | chr12:84579447-84579448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557968895 | chr12:84579530-84579531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189307863 | chr12:84579535-84579536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540559280 | chr12:84579580-84579581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114251195 | chr12:84579602-84579603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201055342 | chr12:84579614-84579615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371395980 | chr12:84579641-84579642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182005647 | chr12:84579672-84579673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374528301 | chr12:84579698-84579699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs578070804 | chr12:84579723-84579724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150245732 | chr12:84579803-84579804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138864635 | chr12:84579817-84579818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116390188 | chr12:84579859-84579860 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs563787144 | chr12:84579882-84579883 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs571071491 | chr12:84579913-84579914 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs7137059 | chr12:84579949-84579950 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs1482435 | chr12:84580004-84580005 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs56982728 | chr12:84580006-84580007 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs185705436 | chr12:84580030-84580031 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs536129250 | chr12:84580078-84580079 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs561307699 | chr12:84580113-84580114 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs550613786 | chr12:84580120-84580121 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs568857946 | chr12:84580157-84580158 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs12305026 | chr12:84580225-84580226 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs557567677 | chr12:84580226-84580227 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs572853308 | chr12:84580230-84580231 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs533748795 | chr12:84580274-84580275 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs555112446 | chr12:84580301-84580302 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs190510247 | chr12:84580329-84580330 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs546974057 | chr12:84580341-84580342 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs367869084 | chr12:84580363-84580364 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs555886410 | chr12:84580364-84580365 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs563370624 | chr12:84580376-84580377 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs575229219 | chr12:84580442-84580443 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs10400559 | chr12:84580459-84580460 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs72615664 | chr12:84580472-84580473 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs528539147 | chr12:84580490-84580491 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs546900369 | chr12:84580525-84580526 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs181165988 | chr12:84580527-84580528 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs569442306 | chr12:84580590-84580591 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs10746315 | chr12:84580607-84580608 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs551275457 | chr12:84580666-84580667 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs374029032 | chr12:84580703-84580704 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs571788393 | chr12:84580725-84580726 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs568921812 | chr12:84580772-84580773 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs186393068 | chr12:84580783-84580784 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs113488596 | chr12:84580802-84580803 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:84578000-84585800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr12:84585200-84586400 | Enhancers | HMEC | breast |
3 | chr12:84585600-84586400 | Enhancers | NHEK | skin |
4 | chr12:84585800-84586600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |